Glucocorticosteroid reversibility testing with oral prednisone (²steroid trial²) for 4 weeks: time-response study using serial spirometry and 6-minute walk distance (6MWD) in patients with moderate to severe stable COPD

M. M. Schuurmans, P. R. Botha, D. Steyn, D. Richter, C. T. Bolliger (Tygerberg, South Africa)

Source: Annual Congress 2004 - Acute exacerbations and drug therapy in COPD
Session: Acute exacerbations and drug therapy in COPD
Session type: Oral Presentation
Number: 2660
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. M. Schuurmans, P. R. Botha, D. Steyn, D. Richter, C. T. Bolliger (Tygerberg, South Africa). Glucocorticosteroid reversibility testing with oral prednisone (²steroid trial²) for 4 weeks: time-response study using serial spirometry and 6-minute walk distance (6MWD) in patients with moderate to severe stable COPD. Eur Respir J 2004; 24: Suppl. 48, 2660

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of formoterol addition on dynamic hyperinflation during 6-minute walk test (6MWT) in moderate to severe COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007


Degree of exercise limitation in COPD: impact on 6 minute walk (6MW) in response to long-acting β-agonist (LABA) treatment
Source: Eur Respir J 2007; 30: Suppl. 51, 76s
Year: 2007

A single dose of tiotropium produces a significant improvement in 6-minute walk distance in severe COPD subjects
Source: Eur Respir J 2005; 26: Suppl. 49, 576s
Year: 2005

Interpretation of treatment changes in 6-minute walk distance in patients with COPD
Source: Eur Respir J 2008; 32: 637-643
Year: 2008



Change in 6 minute walk distance (6MWD) following a familiarisation test and exercise training in patients with chronic obstructive pulmonary disease (COPD): influence of disability
Source: Annual Congress 2008 - Rehabilitation and influencing factors
Year: 2008


Is 6-min walk distance more helpful than FEV1 in evaluating severe COPD patients?
Source: ISSN=ISSN 1810-6838, ISBN=, page=68
Year: 2007

Improvement of 6-minutes walking test (6MWT) and pulmonary functional status after an inpatient pulmonary rehabilitation program (PRP) in moderate-severe and severe COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 244s
Year: 2004

The distance walked in the 6-minute walk test (6MWT) by cases of rhinitis, asthma, and COPD vs. controls: A preliminary report
Source: Annual Congress 2010 - Methods in respiratory epidemiology
Year: 2010

Effects of sildenafil on 6-minute walk distance (6MWD) and WHO functional class (FC) in pulmonary arterial hypertension (PAH) patients after 1 year of treatment
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005


Is a double 6-minute walk test (6MWT) required as part of the routine assessment of pulmonary rehabilitation (PR) in COPD patients?
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014


Six-min walk distance test better reflects maximal exercise tolerance in severe, but not in mild COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 356s
Year: 2001

Inhibitory effect of SABA on exercise dynamic lung hyperinflation during 6-min walk test in stable COPD patients
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011


Predictors of six-minute walk distance at baseline and after three years in COPD patients
Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation
Year: 2011


Follow-up desaturation in 6 minute walk tests and lung function decline in COPD patients
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018



Can diagnostic staff (DS) or patients predict whether the 6-minute walk distance (6MWD) will improve to a relevant extent at a repeated 6-minute walk test (R-6MWT)?
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015


6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID)
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012

Evaluating impairment in exercise capacity in COPD patients with the six-minute walk distance test: a comparative study
Source: Eur Respir J 2006; 28: Suppl. 50, 767s
Year: 2006

Influence of hospitalizations because of COPD exacerbation in the six-minute walk test (6MWT)
Source: International Congress 2015 – COPD: interesting notes
Year: 2015


Comparison of 2- versus 6-minute walking test in patients with severe COPD
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015


Multivariables added to walked distance during 6-min walk test (6MWT) can predict the maximal oxigen consumption (Vo2max) in end-stage renal disease patients
Source: Eur Respir J 2004; 24: Suppl. 48, 405s
Year: 2004